世界のエリブリンメシル酸塩API市場インサイト・予測（～2027年）

• 英文タイトル：Global Eribulin Mesylate API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL1142 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はエリブリンメシル酸塩APIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。エリブリンメシル酸塩APIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（エリブリンメシル酸塩注射剤、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・エリブリンメシル酸塩APIの世界市場概要 ・メーカー別の競争状況、市場シェア ・エリブリンメシル酸塩APIの種類別市場規模：純度≥98％、純度<98％ ・エリブリンメシル酸塩APIの用途別市場規模：エリブリンメシル酸塩注射剤、その他 ・北米のエリブリンメシル酸塩API市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのエリブリンメシル酸塩API市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのエリブリンメシル酸塩API市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のエリブリンメシル酸塩API市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのエリブリンメシル酸塩API市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Dr. Reddy’s Laboratories Ltd.、Transo-Pharm USA LLC、BrightGene Bio-Medical Technology、Wisdom Pharmaceutical Co., Ltd.、Yonsung Fine Chemicals、Mac-Chem Products (India) Pvt.Ltd ・エリブリンメシル酸塩APIのバリューチェーン・販売チャネル分析 ・エリブリンメシル酸塩APIの世界市場動向

Eribulin Mesylate is the mesylate salt of a synthetic analogue of halichondrin B, a substance derived from a marine sponge (Lissodendoryx sp.) with antineoplastic activity. Eribulin binds to the vinca domain of tubulin and inhibits the polymerization of tubulin and the assembly of microtubules, resulting in inhibition of mitotic spindle assembly, induction of cell cycle arrest at G2/M phase, and, potentially, tumor regression.

Market Analysis and Insights: Global Eribulin Mesylate API Market
The global Eribulin Mesylate API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Eribulin Mesylate API Scope and Segment
Eribulin Mesylate API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Eribulin Mesylate API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Eribulin Mesylate Injections Others By Company Dr. Reddy’s Laboratories Ltd. Transo-Pharm USA LLC BrightGene Bio-Medical Technology Wisdom Pharmaceutical Co., Ltd. Yonsung Fine Chemicals Mac-Chem Products (India) Pvt.Ltd Production by Region North America India China South Korea Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Eribulin Mesylate API Product Introduction
1.2 Market by Type
1.2.1 Global Eribulin Mesylate API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Eribulin Mesylate API Market Size Growth Rate by Application 1.3.2 Eribulin Mesylate Injections 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Eribulin Mesylate API Production 2.1 Global Eribulin Mesylate API Production Capacity (2016-2027) 2.2 Global Eribulin Mesylate API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Eribulin Mesylate API Production by Region 2.3.1 Global Eribulin Mesylate API Historic Production by Region (2016-2021) 2.3.2 Global Eribulin Mesylate API Forecasted Production by Region (2022-2027) 2.4 North America 2.5 India 2.6 China 2.7 South Korea 3 Global Eribulin Mesylate API Sales in Volume & Value Estimates and Forecasts 3.1 Global Eribulin Mesylate API Sales Estimates and Forecasts 2016-2027 3.2 Global Eribulin Mesylate API Revenue Estimates and Forecasts 2016-2027 3.3 Global Eribulin Mesylate API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Eribulin Mesylate API Regions by Sales 3.4.1 Global Top Eribulin Mesylate API Regions by Sales (2016-2021) 3.4.2 Global Top Eribulin Mesylate API Regions by Sales (2022-2027) 3.5 Global Top Eribulin Mesylate API Regions by Revenue 3.5.1 Global Top Eribulin Mesylate API Regions by Revenue (2016-2021) 3.5.2 Global Top Eribulin Mesylate API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Eribulin Mesylate API Production Capacity by Manufacturers 4.2 Global Eribulin Mesylate API Sales by Manufacturers 4.2.1 Global Top Eribulin Mesylate API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Eribulin Mesylate API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Eribulin Mesylate API Sales in 2020 4.3 Global Eribulin Mesylate API Revenue by Manufacturers 4.3.1 Global Top Eribulin Mesylate API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Eribulin Mesylate API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Eribulin Mesylate API Revenue in 2020 4.4 Global Eribulin Mesylate API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Eribulin Mesylate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Eribulin Mesylate API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Eribulin Mesylate API Sales by Type 5.1.1 Global Eribulin Mesylate API Historical Sales by Type (2016-2021) 5.1.2 Global Eribulin Mesylate API Forecasted Sales by Type (2022-2027) 5.1.3 Global Eribulin Mesylate API Sales Market Share by Type (2016-2027) 5.2 Global Eribulin Mesylate API Revenue by Type 5.2.1 Global Eribulin Mesylate API Historical Revenue by Type (2016-2021) 5.2.2 Global Eribulin Mesylate API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Eribulin Mesylate API Revenue Market Share by Type (2016-2027) 5.3 Global Eribulin Mesylate API Price by Type 5.3.1 Global Eribulin Mesylate API Price by Type (2016-2021) 5.3.2 Global Eribulin Mesylate API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Eribulin Mesylate API Sales by Application 6.1.1 Global Eribulin Mesylate API Historical Sales by Application (2016-2021) 6.1.2 Global Eribulin Mesylate API Forecasted Sales by Application (2022-2027) 6.1.3 Global Eribulin Mesylate API Sales Market Share by Application (2016-2027) 6.2 Global Eribulin Mesylate API Revenue by Application 6.2.1 Global Eribulin Mesylate API Historical Revenue by Application (2016-2021) 6.2.2 Global Eribulin Mesylate API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Eribulin Mesylate API Revenue Market Share by Application (2016-2027) 6.3 Global Eribulin Mesylate API Price by Application 6.3.1 Global Eribulin Mesylate API Price by Application (2016-2021) 6.3.2 Global Eribulin Mesylate API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Eribulin Mesylate API Market Size by Type 7.1.1 North America Eribulin Mesylate API Sales by Type (2016-2027) 7.1.2 North America Eribulin Mesylate API Revenue by Type (2016-2027) 7.2 North America Eribulin Mesylate API Market Size by Application 7.2.1 North America Eribulin Mesylate API Sales by Application (2016-2027) 7.2.2 North America Eribulin Mesylate API Revenue by Application (2016-2027) 7.3 North America Eribulin Mesylate API Sales by Country 7.3.1 North America Eribulin Mesylate API Sales by Country (2016-2027) 7.3.2 North America Eribulin Mesylate API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Eribulin Mesylate API Market Size by Type 8.1.1 Europe Eribulin Mesylate API Sales by Type (2016-2027) 8.1.2 Europe Eribulin Mesylate API Revenue by Type (2016-2027) 8.2 Europe Eribulin Mesylate API Market Size by Application 8.2.1 Europe Eribulin Mesylate API Sales by Application (2016-2027) 8.2.2 Europe Eribulin Mesylate API Revenue by Application (2016-2027) 8.3 Europe Eribulin Mesylate API Sales by Country 8.3.1 Europe Eribulin Mesylate API Sales by Country (2016-2027) 8.3.2 Europe Eribulin Mesylate API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Eribulin Mesylate API Market Size by Type 9.1.1 Asia Pacific Eribulin Mesylate API Sales by Type (2016-2027) 9.1.2 Asia Pacific Eribulin Mesylate API Revenue by Type (2016-2027) 9.2 Asia Pacific Eribulin Mesylate API Market Size by Application 9.2.1 Asia Pacific Eribulin Mesylate API Sales by Application (2016-2027) 9.2.2 Asia Pacific Eribulin Mesylate API Revenue by Application (2016-2027) 9.3 Asia Pacific Eribulin Mesylate API Sales by Region 9.3.1 Asia Pacific Eribulin Mesylate API Sales by Region (2016-2027) 9.3.2 Asia Pacific Eribulin Mesylate API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Eribulin Mesylate API Market Size by Type 10.1.1 Latin America Eribulin Mesylate API Sales by Type (2016-2027) 10.1.2 Latin America Eribulin Mesylate API Revenue by Type (2016-2027) 10.2 Latin America Eribulin Mesylate API Market Size by Application 10.2.1 Latin America Eribulin Mesylate API Sales by Application (2016-2027) 10.2.2 Latin America Eribulin Mesylate API Revenue by Application (2016-2027) 10.3 Latin America Eribulin Mesylate API Sales by Country 10.3.1 Latin America Eribulin Mesylate API Sales by Country (2016-2027) 10.3.2 Latin America Eribulin Mesylate API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Eribulin Mesylate API Market Size by Type 11.1.1 Middle East and Africa Eribulin Mesylate API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Eribulin Mesylate API Revenue by Type (2016-2027) 11.2 Middle East and Africa Eribulin Mesylate API Market Size by Application 11.2.1 Middle East and Africa Eribulin Mesylate API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Eribulin Mesylate API Revenue by Application (2016-2027) 11.3 Middle East and Africa Eribulin Mesylate API Sales by Country 11.3.1 Middle East and Africa Eribulin Mesylate API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Eribulin Mesylate API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Dr. Reddy’s Laboratories Ltd. 12.1.1 Dr. Reddy’s Laboratories Ltd. Corporation Information 12.1.2 Dr. Reddy’s Laboratories Ltd. Overview 12.1.3 Dr. Reddy’s Laboratories Ltd. Eribulin Mesylate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Dr. Reddy’s Laboratories Ltd. Eribulin Mesylate API Product Description 12.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments 12.2 Transo-Pharm USA LLC 12.2.1 Transo-Pharm USA LLC Corporation Information 12.2.2 Transo-Pharm USA LLC Overview 12.2.3 Transo-Pharm USA LLC Eribulin Mesylate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Transo-Pharm USA LLC Eribulin Mesylate API Product Description 12.2.5 Transo-Pharm USA LLC Recent Developments 12.3 BrightGene Bio-Medical Technology 12.3.1 BrightGene Bio-Medical Technology Corporation Information 12.3.2 BrightGene Bio-Medical Technology Overview 12.3.3 BrightGene Bio-Medical Technology Eribulin Mesylate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 BrightGene Bio-Medical Technology Eribulin Mesylate API Product Description 12.3.5 BrightGene Bio-Medical Technology Recent Developments 12.4 Wisdom Pharmaceutical Co., Ltd. 12.4.1 Wisdom Pharmaceutical Co., Ltd. Corporation Information 12.4.2 Wisdom Pharmaceutical Co., Ltd. Overview 12.4.3 Wisdom Pharmaceutical Co., Ltd. Eribulin Mesylate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Wisdom Pharmaceutical Co., Ltd. Eribulin Mesylate API Product Description 12.4.5 Wisdom Pharmaceutical Co., Ltd. Recent Developments 12.5 Yonsung Fine Chemicals 12.5.1 Yonsung Fine Chemicals Corporation Information 12.5.2 Yonsung Fine Chemicals Overview 12.5.3 Yonsung Fine Chemicals Eribulin Mesylate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Yonsung Fine Chemicals Eribulin Mesylate API Product Description 12.5.5 Yonsung Fine Chemicals Recent Developments 12.6 Mac-Chem Products (India) Pvt.Ltd 12.6.1 Mac-Chem Products (India) Pvt.Ltd Corporation Information 12.6.2 Mac-Chem Products (India) Pvt.Ltd Overview 12.6.3 Mac-Chem Products (India) Pvt.Ltd Eribulin Mesylate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Mac-Chem Products (India) Pvt.Ltd Eribulin Mesylate API Product Description 12.6.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Eribulin Mesylate API Industry Chain Analysis 13.2 Eribulin Mesylate API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Eribulin Mesylate API Production Mode & Process 13.4 Eribulin Mesylate API Sales and Marketing 13.4.1 Eribulin Mesylate API Sales Channels 13.4.2 Eribulin Mesylate API Distributors 13.5 Eribulin Mesylate API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Eribulin Mesylate API Industry Trends 14.2 Eribulin Mesylate API Market Drivers 14.3 Eribulin Mesylate API Market Challenges 14.4 Eribulin Mesylate API Market Restraints 15 Key Finding in The Global Eribulin Mesylate API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Eribulin Mesylate API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Eribulin Mesylate API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Eribulin Mesylate API Production by Region: 2016 VS 2021 VS 2027 (Kiloton)
Table 6. Global Eribulin Mesylate API Production by Region (2016-2021) & (Kiloton)
Table 7. Global Eribulin Mesylate API Production Market Share by Region (2016-2021)
Table 8. Global Eribulin Mesylate API Production by Region (2022-2027) & (Kiloton)
Table 9. Global Eribulin Mesylate API Production Market Share by Region (2022-2027)
Table 10. Global Eribulin Mesylate API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Eribulin Mesylate API Sales by Region (2016-2021) & (Kiloton)
Table 12. Global Eribulin Mesylate API Sales Market Share by Region (2016-2021)
Table 13. Global Eribulin Mesylate API Sales by Region (2022-2027) & (Kiloton)
Table 14. Global Eribulin Mesylate API Sales Market Share by Region (2022-2027)
Table 15. Global Eribulin Mesylate API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Eribulin Mesylate API Revenue Market Share by Region (2016-2021)
Table 17. Global Eribulin Mesylate API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Eribulin Mesylate API Revenue Market Share by Region (2022-2027)
Table 19. Global Eribulin Mesylate API Production Capacity by Manufacturers (2016-2021) & (Kiloton)
Table 20. Global Eribulin Mesylate API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Eribulin Mesylate API Production by Manufacturers (2016-2021) & (Kiloton)
Table 22. Global Eribulin Mesylate API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Eribulin Mesylate API Sales by Manufacturers (2016-2021) & (Kiloton)
Table 24. Global Eribulin Mesylate API Sales Share by Manufacturers (2016-2021)
Table 25. Global Eribulin Mesylate API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Eribulin Mesylate API Revenue Share by Manufacturers (2016-2021)
Table 27. Eribulin Mesylate API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Eribulin Mesylate API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Eribulin Mesylate API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eribulin Mesylate API as of 2020)
Table 30. Eribulin Mesylate API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Eribulin Mesylate API Product Offered
Table 32. Date of Manufacturers Enter into Eribulin Mesylate API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Eribulin Mesylate API Sales by Type (2016-2021) & (Kiloton)
Table 35. Global Eribulin Mesylate API Sales by Type (2022-2027) & (Kiloton)
Table 36. Global Eribulin Mesylate API Sales Share by Type (2016-2021)
Table 37. Global Eribulin Mesylate API Sales Share by Type (2022-2027)
Table 38. Global Eribulin Mesylate API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Eribulin Mesylate API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Eribulin Mesylate API Revenue Share by Type (2016-2021)
Table 41. Global Eribulin Mesylate API Revenue Share by Type (2022-2027)
Table 42. Eribulin Mesylate API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Eribulin Mesylate API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Eribulin Mesylate API Sales by Application (2016-2021) & (Kiloton)
Table 45. Global Eribulin Mesylate API Sales by Application (2022-2027) & (Kiloton)
Table 46. Global Eribulin Mesylate API Sales Share by Application (2016-2021)
Table 47. Global Eribulin Mesylate API Sales Share by Application (2022-2027)
Table 48. Global Eribulin Mesylate API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Eribulin Mesylate API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Eribulin Mesylate API Revenue Share by Application (2016-2021)
Table 51. Global Eribulin Mesylate API Revenue Share by Application (2022-2027)
Table 52. Eribulin Mesylate API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Eribulin Mesylate API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Eribulin Mesylate API Sales by Type (2016-2021) & (Kiloton)
Table 55. North America Eribulin Mesylate API Sales by Type (2022-2027) & (Kiloton)
Table 56. North America Eribulin Mesylate API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Eribulin Mesylate API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Eribulin Mesylate API Sales by Application (2016-2021) & (Kiloton)
Table 59. North America Eribulin Mesylate API Sales by Application (2022-2027) & (Kiloton)
Table 60. North America Eribulin Mesylate API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Eribulin Mesylate API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Eribulin Mesylate API Sales by Country (2016-2021) & (Kiloton)
Table 63. North America Eribulin Mesylate API Sales by Country (2022-2027) & (Kiloton)
Table 64. North America Eribulin Mesylate API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Eribulin Mesylate API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Eribulin Mesylate API Sales by Type (2016-2021) & (Kiloton)
Table 67. Europe Eribulin Mesylate API Sales by Type (2022-2027) & (Kiloton)
Table 68. Europe Eribulin Mesylate API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Eribulin Mesylate API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Eribulin Mesylate API Sales by Application (2016-2021) & (Kiloton)
Table 71. Europe Eribulin Mesylate API Sales by Application (2022-2027) & (Kiloton)
Table 72. Europe Eribulin Mesylate API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Eribulin Mesylate API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Eribulin Mesylate API Sales by Country (2016-2021) & (Kiloton)
Table 75. Europe Eribulin Mesylate API Sales by Country (2022-2027) & (Kiloton)
Table 76. Europe Eribulin Mesylate API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Eribulin Mesylate API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Eribulin Mesylate API Sales by Type (2016-2021) & (Kiloton)
Table 79. Asia Pacific Eribulin Mesylate API Sales by Type (2022-2027) & (Kiloton)
Table 80. Asia Pacific Eribulin Mesylate API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Eribulin Mesylate API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Eribulin Mesylate API Sales by Application (2016-2021) & (Kiloton)
Table 83. Asia Pacific Eribulin Mesylate API Sales by Application (2022-2027) & (Kiloton)
Table 84. Asia Pacific Eribulin Mesylate API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Eribulin Mesylate API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Eribulin Mesylate API Sales by Region (2016-2021) & (Kiloton)
Table 87. Asia Pacific Eribulin Mesylate API Sales by Region (2022-2027) & (Kiloton)
Table 88. Asia Pacific Eribulin Mesylate API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Eribulin Mesylate API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Eribulin Mesylate API Sales by Type (2016-2021) & (Kiloton)
Table 91. Latin America Eribulin Mesylate API Sales by Type (2022-2027) & (Kiloton)
Table 92. Latin America Eribulin Mesylate API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Eribulin Mesylate API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Eribulin Mesylate API Sales by Application (2016-2021) & (Kiloton)
Table 95. Latin America Eribulin Mesylate API Sales by Application (2022-2027) & (Kiloton)
Table 96. Latin America Eribulin Mesylate API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Eribulin Mesylate API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Eribulin Mesylate API Sales by Country (2016-2021) & (Kiloton)
Table 99. Latin America Eribulin Mesylate API Sales by Country (2022-2027) & (Kiloton)
Table 100. Latin America Eribulin Mesylate API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Eribulin Mesylate API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Eribulin Mesylate API Sales by Type (2016-2021) & (Kiloton)
Table 103. Middle East and Africa Eribulin Mesylate API Sales by Type (2022-2027) & (Kiloton)
Table 104. Middle East and Africa Eribulin Mesylate API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Eribulin Mesylate API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Eribulin Mesylate API Sales by Application (2016-2021) & (Kiloton)
Table 107. Middle East and Africa Eribulin Mesylate API Sales by Application (2022-2027) & (Kiloton)
Table 108. Middle East and Africa Eribulin Mesylate API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Eribulin Mesylate API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Eribulin Mesylate API Sales by Country (2016-2021) & (Kiloton)
Table 111. Middle East and Africa Eribulin Mesylate API Sales by Country (2022-2027) & (Kiloton)
Table 112. Middle East and Africa Eribulin Mesylate API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Eribulin Mesylate API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Dr. Reddy’s Laboratories Ltd. Corporation Information
Table 115. Dr. Reddy’s Laboratories Ltd. Description and Major Businesses
Table 116. Dr. Reddy’s Laboratories Ltd. Eribulin Mesylate API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Dr. Reddy’s Laboratories Ltd. Eribulin Mesylate API Product
Table 118. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 119. Transo-Pharm USA LLC Corporation Information
Table 120. Transo-Pharm USA LLC Description and Major Businesses
Table 121. Transo-Pharm USA LLC Eribulin Mesylate API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Transo-Pharm USA LLC Eribulin Mesylate API Product
Table 123. Transo-Pharm USA LLC Recent Development
Table 124. BrightGene Bio-Medical Technology Corporation Information
Table 125. BrightGene Bio-Medical Technology Description and Major Businesses
Table 126. BrightGene Bio-Medical Technology Eribulin Mesylate API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. BrightGene Bio-Medical Technology Eribulin Mesylate API Product
Table 128. BrightGene Bio-Medical Technology Recent Development
Table 129. Wisdom Pharmaceutical Co., Ltd. Corporation Information
Table 130. Wisdom Pharmaceutical Co., Ltd. Description and Major Businesses
Table 131. Wisdom Pharmaceutical Co., Ltd. Eribulin Mesylate API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Wisdom Pharmaceutical Co., Ltd. Eribulin Mesylate API Product
Table 133. Wisdom Pharmaceutical Co., Ltd. Recent Development
Table 134. Yonsung Fine Chemicals Corporation Information
Table 135. Yonsung Fine Chemicals Description and Major Businesses
Table 136. Yonsung Fine Chemicals Eribulin Mesylate API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Yonsung Fine Chemicals Eribulin Mesylate API Product
Table 138. Yonsung Fine Chemicals Recent Development
Table 139. Mac-Chem Products (India) Pvt.Ltd Corporation Information
Table 140. Mac-Chem Products (India) Pvt.Ltd Description and Major Businesses
Table 141. Mac-Chem Products (India) Pvt.Ltd Eribulin Mesylate API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Mac-Chem Products (India) Pvt.Ltd Eribulin Mesylate API Product
Table 143. Mac-Chem Products (India) Pvt.Ltd Recent Development
Table 144. Key Raw Materials Lists
Table 145. Raw Materials Key Suppliers Lists
Table 146. Eribulin Mesylate API Distributors List
Table 147. Eribulin Mesylate API Customers List
Table 148. Eribulin Mesylate API Market Trends
Table 149. Eribulin Mesylate API Market Drivers
Table 150. Eribulin Mesylate API Market Challenges
Table 151. Eribulin Mesylate API Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Eribulin Mesylate API Product Picture
Figure 2. Global Eribulin Mesylate API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Eribulin Mesylate API Market Share by Application in 2020 & 2027
Figure 6. Eribulin Mesylate Injections
Figure 7. Others
Figure 8. Eribulin Mesylate API Report Years Considered
Figure 9. Global Eribulin Mesylate API Capacity, Production and Utilization (2016-2027) & (Kiloton)
Figure 10. Global Eribulin Mesylate API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Eribulin Mesylate API Production Market Share by Region (2016-2021)
Figure 12. Global Eribulin Mesylate API Production Market Share by Region (2022-2027)
Figure 13. Eribulin Mesylate API Production Growth Rate in North America (2016-2027) & (Kiloton)
Figure 14. Eribulin Mesylate API Production Growth Rate in India (2016-2027) & (Kiloton)
Figure 15. Eribulin Mesylate API Production Growth Rate in China (2016-2027) & (Kiloton)
Figure 16. Eribulin Mesylate API Production Growth Rate in South Korea (2016-2027) & (Kiloton)
Figure 17. Global Eribulin Mesylate API Sales 2016-2027 (Kiloton)
Figure 18. Global Eribulin Mesylate API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Eribulin Mesylate API Revenue 2016-2027 (US$ Million)
Figure 20. Global Eribulin Mesylate API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Eribulin Mesylate API Sales Market Share by Region (2016-2021)
Figure 22. Global Eribulin Mesylate API Sales Market Share by Region (2022-2027)
Figure 23. North America Eribulin Mesylate API Sales YoY (2016-2027) & (Kiloton)
Figure 24. North America Eribulin Mesylate API Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Eribulin Mesylate API Sales YoY (2016-2027) & (Kiloton)
Figure 26. Europe Eribulin Mesylate API Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Eribulin Mesylate API Sales YoY (2016-2027) & (Kiloton)
Figure 28. Asia-Pacific Eribulin Mesylate API Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Eribulin Mesylate API Sales YoY (2016-2027) & (Kiloton)
Figure 30. Latin America Eribulin Mesylate API Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Eribulin Mesylate API Sales YoY (2016-2027) & (Kiloton)
Figure 32. Middle East & Africa Eribulin Mesylate API Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Eribulin Mesylate API Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Eribulin Mesylate API Revenue in 2020
Figure 35. Eribulin Mesylate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Eribulin Mesylate API Sales Market Share by Type (2016-2027)
Figure 37. Global Eribulin Mesylate API Revenue Market Share by Type (2016-2027)
Figure 38. Global Eribulin Mesylate API Sales Market Share by Application (2016-2027)
Figure 39. Global Eribulin Mesylate API Revenue Market Share by Application (2016-2027)
Figure 40. North America Eribulin Mesylate API Sales Market Share by Type (2016-2027)
Figure 41. North America Eribulin Mesylate API Revenue Market Share by Type (2016-2027)
Figure 42. North America Eribulin Mesylate API Sales Market Share by Application (2016-2027)
Figure 43. North America Eribulin Mesylate API Revenue Market Share by Application (2016-2027)
Figure 44. North America Eribulin Mesylate API Sales Share by Country (2016-2027)
Figure 45. North America Eribulin Mesylate API Revenue Share by Country (2016-2027)
Figure 46. United States Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Eribulin Mesylate API Sales Market Share by Type (2016-2027)
Figure 49. Europe Eribulin Mesylate API Revenue Market Share by Type (2016-2027)
Figure 50. Europe Eribulin Mesylate API Sales Market Share by Application (2016-2027)
Figure 51. Europe Eribulin Mesylate API Revenue Market Share by Application (2016-2027)
Figure 52. Europe Eribulin Mesylate API Sales Share by Country (2016-2027)
Figure 53. Europe Eribulin Mesylate API Revenue Share by Country (2016-2027)
Figure 54. Germany Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 55. France Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Eribulin Mesylate API Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Eribulin Mesylate API Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Eribulin Mesylate API Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Eribulin Mesylate API Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Eribulin Mesylate API Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Eribulin Mesylate API Revenue Share by Region (2016-2027)
Figure 65. China Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 68. India Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 70. China Taiwan Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 74. Latin America Eribulin Mesylate API Sales Market Share by Type (2016-2027)
Figure 75. Latin America Eribulin Mesylate API Revenue Market Share by Type (2016-2027)
Figure 76. Latin America Eribulin Mesylate API Sales Market Share by Application (2016-2027)
Figure 77. Latin America Eribulin Mesylate API Revenue Market Share by Application (2016-2027)
Figure 78. Latin America Eribulin Mesylate API Sales Share by Country (2016-2027)
Figure 79. Latin America Eribulin Mesylate API Revenue Share by Country (2016-2027)
Figure 80. Mexico Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 81. Brazil Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 82. Argentina Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 83. Middle East and Africa Eribulin Mesylate API Sales Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Eribulin Mesylate API Revenue Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Eribulin Mesylate API Sales Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Eribulin Mesylate API Revenue Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Eribulin Mesylate API Sales Share by Country (2016-2027)
Figure 88. Middle East and Africa Eribulin Mesylate API Revenue Share by Country (2016-2027)
Figure 89. Turkey Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 90. Saudi Arabia Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 91. UAE Eribulin Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 92. Eribulin Mesylate API Value Chain
Figure 93. Eribulin Mesylate API Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

---